ACUPAN

This brand name is authorized in France, New Zealand, Nigeria, Romania, Tunisia, UK.

Active ingredients

The drug ACUPAN contains one active pharmaceutical ingredient (API):

1
UNII 685J48E13W - NEFOPAM HYDROCHLORIDE
 
Read more about Nefopam

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ACUPAN Tablet MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02BG06 Nefopam N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics
Discover more medicines within N02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 62580656
NG Registered Drug Product Database A4-5504
Switch country to Nigeria in order to find specific presentations of ACUPAN
NZ Medicines and Medical Devices Safety Authority 2482
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W43861001, W43861002
TN Direction de la Pharmacie et du Médicament 5193031

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈